Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Milrinone pharmacokinetics and haemodynamic effects after PDA ligation in preterm neonates
2015-000486-31Phase 4Completed
- Sponsor
- Department of Anaesthesiology and Intensive Care, University of Tartu
- Start
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of milrinone in post-ligation cardiac syndrome (PLCS) and patent ductus arteriosus (PDA) (2 arms), sponsored by Department of Anaesthesiology and Intensive Care, University of Tartu. Primary endpoint: Pharmacokinetics of milrinone. Started May 2015; status: completed.
02
Drugs
milrinone
03
Conditions
post-ligation cardiac syndrome (PLCS)patent ductus arteriosus (PDA)
Beyond the preview
Go deeper on 2015-000486-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-000486-31.